TNF and ulcerative colitis: Increased TNF-α levels in patients with autoimmune disease led to the development of TNF-α inhibitors, such as infliximab and etanercept, which are very efficient in the management of rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and other autoimmune disorders [118].